What is a stock summary page? Click here for an overview.
Business Description
Merck KGaA
NAICS : 325412
SIC : 2834
ISIN : DE0006599905
Share Class Description:
MKGAF: Ordinary SharesCompare
Compare
Traded in other countries / regions
MRK.Germany0O14.UKMKKGY.USA1MRK.ItalyMRCK.AustriaMRK.BulgariaMER.SwitzerlandMRK1.Mexico IPO Date
2013-04-17Description
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | 1.72 | |||||
| Interest Coverage | 13.67 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.84 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.4 | |||||
| 3-Year EPS without NRI Growth Rate | 0.2 | |||||
| 3-Year FCF Growth Rate | -9.1 | |||||
| 3-Year Book Growth Rate | 11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.99 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.94 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.76 | |||||
| 9-Day RSI | 50.26 | |||||
| 14-Day RSI | 48.97 | |||||
| 3-1 Month Momentum % | -4.13 | |||||
| 6-1 Month Momentum % | -16.46 | |||||
| 12-1 Month Momentum % | -17.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.79 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 193.26 | |||||
| Days Sales Outstanding | 70.22 | |||||
| Days Payable | 79.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.92 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 16.3 | |||||
| Forward Dividend Yield % | 1.86 | |||||
| 5-Year Yield-on-Cost % | 3.75 | |||||
| Shareholder Yield % | 1.87 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.01 | |||||
| Operating Margin % | 19 | |||||
| Net Margin % | 13.13 | |||||
| FCF Margin % | 11.36 | |||||
| ROE % | 9.82 | |||||
| ROA % | 5.56 | |||||
| ROIC % | 7.28 | |||||
| 3-Year ROIIC % | -2.68 | |||||
| ROC (Joel Greenblatt) % | 31.67 | |||||
| ROCE % | 9.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.8 | |||||
| Forward PE Ratio | 12.79 | |||||
| PE Ratio without NRI | 15.97 | |||||
| Shiller PE Ratio | 18.62 | |||||
| Price-to-Owner-Earnings | 16.61 | |||||
| PEG Ratio | 2.35 | |||||
| PS Ratio | 2.34 | |||||
| PB Ratio | 1.72 | |||||
| Price-to-Tangible-Book | 11.52 | |||||
| Price-to-Free-Cash-Flow | 20.54 | |||||
| Price-to-Operating-Cash-Flow | 10.74 | |||||
| EV-to-EBIT | 15.99 | |||||
| EV-to-Forward-EBIT | 14.66 | |||||
| EV-to-EBITDA | 10.28 | |||||
| EV-to-Forward-EBITDA | 9.62 | |||||
| EV-to-Revenue | 2.9 | |||||
| EV-to-Forward-Revenue | 2.8 | |||||
| EV-to-FCF | 26.12 | |||||
| Price-to-GF-Value | 0.71 | |||||
| Price-to-Projected-FCF | 1.04 | |||||
| Price-to-DCF (Earnings Based) | 0.79 | |||||
| Price-to-DCF (FCF Based) | 1.52 | |||||
| Price-to-Median-PS-Value | 0.8 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.78 | |||||
| Price-to-Graham-Number | 2.91 | |||||
| Earnings Yield (Greenblatt) % | 6.25 | |||||
| FCF Yield % | 5.15 | |||||
| Forward Rate of Return (Yacktman) % | 10.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MKGAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Merck KGaA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22,844.165 | ||
| EPS (TTM) ($) | 6.923 | ||
| Beta | 0.82 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 31.15 | ||
| 14-Day RSI | 48.97 | ||
| 14-Day ATR ($) | 6.28245 | ||
| 20-Day SMA ($) | 143.29615 | ||
| 12-1 Month Momentum % | -17.32 | ||
| 52-Week Range ($) | 123.259 - 200.56 | ||
| Shares Outstanding (Mil) | 434.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Merck KGaA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Merck KGaA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Merck KGaA Frequently Asked Questions
What is Merck KGaA(MKGAF)'s stock price today?
The current price of MKGAF is $123.26. The 52 week high of MKGAF is $200.56 and 52 week low is $123.26.
When is next earnings date of Merck KGaA(MKGAF)?
The next earnings date of Merck KGaA(MKGAF) is 2025-05-15.
Does Merck KGaA(MKGAF) pay dividends? If so, how much?
The Dividend Yield %  of Merck KGaA(MKGAF) is 1.92% (As of Today), Highest Dividend Payout Ratio of Merck KGaA(MKGAF) was 0.48. The lowest was 0.2. And the median was 0.31. The  Forward Dividend Yield % of Merck KGaA(MKGAF) is 1.86%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers